Public announcement
The “Guarantors of EQIPD” officially announced their launch with a public press release. The society is registered since December 2021 and became fully operational now.
Similar Posts
EQIPD Newsletter 6 – Spring 2020
ByadminThe EQIPD project was highlighted in a recent publication by DDNews and will be featured at this year’s ECNP ‘campfire sessions’, the ‘Handbook on Good Research Practice in Non-Clinical Pharmacology and Biomedicine’ about quality in preclinical research has just been published, and the Global Preclinical Data Forum (GPDF) is giving out an award on the…
Aligned on quality
ByadminOn October 10, 2022, #EQIPD will lead a discussion on how to help funders and grant applicants align on research rigor expectations and avoid funding of research of unknown quality. Objectives of the meeting are to: Review lessons learned from the US and German publicly funded programs that focused directly or indirectly on decision-enabling research…
EQIPD Newsletter 3 – Spring 2019
ByadminCheck out the updates on the outcome of the Alzheimer systematic review, the EQIPD brainstorming session at ECNP, and more in the newest version of our newsletter! Read the Newsletter here.
2nd EQIPD Newsletter – Fall 2018
ByadminThe EQIPD project was presented at the PreNeuroscience 2018 Seminar and Networking event that took place on 2 November 2018 inconjunction with the Society for Neuroscience’s (SfN) annual meeting in San Diego, California, USA, to create awareness in the USA as well – Download our 2nd newsletter to see more updates and news! Read the…
EQIPD Newsletter 7 – Spring 2020
ByadminIn the newest edition of the newsletter, find out more about the highlights of the EQIPD General Assembly meeting, the new project collaborations, CAMARADES winning the BNA’s ‘Credibility Prize’ and details on the 34th ECNP congress. Read the Newsletter here.
Malcolm and Thomas take EQIPD to NATURE
ByadminEQIPD and our efforts to ” Unclog pipeline for new medicines” is mentioned in form of a brief article in NATURE CORRESPONDENCE. Click here to get to the article!